
KODA, popular gospel artiste dies, unseen video of his wrong prescription by doctors surfaces
KODA’s untimely death has sent shocks down the spine of Ghanaians and the gospel fraternity. The announcement o his demise has circulated across all social media platforms as fans share their condolences to the family of the talented and award-winning gospel artiste.
Kofi Owusu Dua Anto, often known as KODA, was a well-known gospel performer in Ghana who regrettably departed suddenly.
Nii Okai, a fellow gospel performer and personal friend, verified the devastating news. “During the early hours of Sunday, April 21, 2024, KODA made the shift to greatness. As we process this loss, let’s join together in prayer for his family,” he said.
Although the circumstances surrounding his death are unknown, unconfirmed reports indicate that he passed away from a disease he had been battling. His age was forty-five. Based in Takoradi, which is located in Ghana’s Western Region, KODA was a well-known gospel singer, composer, music producer, and multi-instrumentalist from Ghana.
Widely recognised for his unique input into Ghana’s modern gospel music landscape, KODA was a multi-award winning performer. He had a strong desire to share the gospel, and via his producing efforts, he significantly influenced the direction of the music industry.
Collaborations with renowned individuals like the late Danny Nettey, Pastor Joe Beechem, Nii Okai, Halal Afrika, Eugene Zuta, and many more are included in his portfolio, cementing his reputation as a diverse and significant force in Ghanaian gospel music.
A video of the ;ate artiste detailing how he narrated his wrong prescription has surfaced on the internet, making fans wonder if his demise is linked to the wrong prescription he had complained about in the trending interview.
Watch KODA’s interview on his wrong prescription below:
@fact_check10 I was given a wrong medication – KODA #SerwaaAmihere #Baltimore #creatorstudio #factcheck #effecthouse #tiktok #AbenaKorkor ♬ original sound – 🄵🄰🄲🅃 🄲🄷🄴🄲🄺
follow our social media platforms.